Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19
Abstract
:1. Introduction
2. Materials and Methods
3. Case Presentation
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Douglas, M.; Katikireddi, S.V.; Taulbut, M.; McKee, M.; McCartney, G. Mitigating the wider health effects of covid-19 pandemic response. BMJ 2020, 369, m1557. [Google Scholar] [CrossRef] [PubMed]
- Ackermann, M.; Verleden, S.E.; Kuehnel, M.; Haverich, A.; Welte, T.; Laenger, F.; Vanstapel, A.; Werlein, C.; Stark, H.; Tzankov, A.; et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020, 383, 120–128. [Google Scholar] [CrossRef]
- Zhou, F.; Yu, T.; Du, R.; Fan, G.; Liu, Y.; Liu, Z.; Xiang, J.; Wang, Y.; Song, B.; Gu, X.; et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020, 395, 1054–1062. [Google Scholar] [CrossRef]
- Guan, W.; Ni, Z.; Hu, Y.Y.; Liang, Z.; Liang, W.; Ou, C.; He, J.; Liu, Y.; Liu, J.; Hui, D.S.; et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020, 382, 1708–1720. [Google Scholar] [CrossRef] [PubMed]
- Vetter, P.; Vu, D.L.; L’Huillier, A.G.; Schibler, M.L.; Jacquerioz, F. Clinical features of covid-19. BMJ 2020, 369, m1470. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Connors, J.M.; Levy, J.H. Thromboinflammation and the hypercoagulability of COVID-19. J. Thromb. Haemost. 2020, 18, 1559–1561. [Google Scholar] [CrossRef] [PubMed]
- Słomka, A.; Kowalewski, M.; Żekanowska, E. Hemostasis in Coronavirus Disease 2019—Lesson from Viscoelastic Methods: A Systematic Review. Thromb. Haemost. 2021. [Google Scholar] [CrossRef]
- Lee, S.G.; Fralick, M.; Sholzberg, M. Coagulopathy associated with COVID-19. CMAJ 2020, 192, E583. [Google Scholar] [CrossRef]
- Oxley, T.J.; Mocco, J.; Majidi, S.; Kellner, C.P.; Shoirah, H.; Singh, I.P.; Reade, A.; Shigematsu, T.; Ladner, T.R.; Yaeger, K.A.; et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N. Engl. J. Med. 2020, 382, e60. [Google Scholar] [CrossRef]
- Galanis, N.; Stavraka, C.; Agathangelidis, F.; Petsatodis, E.; Giankoulof, C.; Givissis, P. Coagulopathy in COVID-19 infection: A case of acute upper limb ischemia. J. Surg. Case Rep. 2020, 2020. [Google Scholar] [CrossRef]
- Llitjos, J.F.; Leclerc, M.; Chochois, C.; Monsallier, J.; Ramakers, M.; Auvray, M.; Merouani, K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J. Thromb. Haemost. 2020, 18, 1743–1746. [Google Scholar] [CrossRef]
- Ren, B.; Yan, F.; Deng, Z.; Zhang, S.; Xiao, L.; Wu, M.; Cai, L. Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan. Circulation 2020, 142, 181–183. [Google Scholar] [CrossRef]
- Chang, H.; Rockman, C.B.; Jacobowitz, G.R.; Speranza, G.; Johnson, W.S.; Horowitz, J.M.; Garg, K.; Maldonado, T.S.; Sadek, M.; Barfield, M.E. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019. J. Vasc. Surgery. Venous Lymphat. Disord. 2020, S2213-333X, 30543–30546. [Google Scholar] [CrossRef]
- Saseedharan, S.; Bhargava, S. Upper extremity deep vein thrombosis. Int. J. Crit. Illn. Inj. Sci. 2012, 2, 21–26. [Google Scholar] [CrossRef] [Green Version]
- Flinterman, L.E.; Van Der Meer, F.J.; Rosendaal, F.R.; Doggen, C.J. Current perspective of venous thrombosis in the upper extremity. J. Thromb. Haemost. 2008, 6, 1262–1266. [Google Scholar] [CrossRef]
- Heil, J.; Miesbach, W.; Vogl, T.; Bechstein, W.O.; Reinisch, A. Deep vein thrombosis of the upper extremity. Dtsch. Ärzteblatt Int. 2017, 114, 244–249. [Google Scholar] [CrossRef] [Green Version]
- Spiezia, L.; Simioni, P. Upper extremity deep vein thrombosis. Intern. Emerg. Med. 2010, 5, 103–109. [Google Scholar] [CrossRef] [PubMed]
- Sajid, M.S.; Ahmed, N.; Desai, M.; Baker, D.; Hamilton, G. Upper limb deep vein thrombosis: A literature review to streamline the protocol for management. Acta Haematol. 2007, 118, 10–18. [Google Scholar] [CrossRef]
- Alla, V.M.; Natarajan, N.; Kaushik, M.; Warrier, R.; Nair, C.K. Paget-schroetter syndrome: Review of pathogenesis and treatment of effort thrombosis. West. J. Emerg. Med. 2010, 11, 358–362. [Google Scholar]
- Hingorani, A.; Ascher, E.; Markevich, N.; Yorkovich, W.; Schutzer, R.; Mutyala, M.; Nahata, S.; Jacob, T. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. J. Vasc. Surg. 2005, 41, 476–478. [Google Scholar] [CrossRef] [PubMed]
- Yamashita, Y.; Morimoto, T.; Amano, H.; Takase, T.; Hiramori, S.; Kim, K.; Oi, M.; Akao, M.; Kobayashi, Y.; Toyofuku, M.; et al. Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry. Thromb. Res. 2019, 177, 1–9. [Google Scholar] [CrossRef]
- Bozzani, A.; Arici, V.; Franciscone, M.M.; Danesino, V.; Cascina, A.; Ticozzelli, G.; Ragni, F. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and the Upper Limb Deep Vein Thrombosis Risk. Ann. Vasc. Surg. 2020, 66, 11–13. [Google Scholar] [CrossRef]
- Marone, E.M.; Rinaldi, L.F. Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations. J. Vasc. Surgery. Venous Lymphat. Disord. 2020, 8, 694–695. [Google Scholar] [CrossRef]
- Joffe, H.V.; Kucher, N.; Tapson, V.F.; Goldhaber, S.Z. Deep Vein Thrombosis (DVT) FREE Steering Committee. Upper-extremity deep vein thrombosis: A prospective registry of 592 patients. Circulation 2004, 110, 1605–1611. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Rooden, C.J.; Molhoek, S.G.; Rosendaal, F.R.; Schalij, M.J.; Meinders, A.E.; Huisman, M.V. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J. Cardiovasc. Electrophysiol. 2004, 15, 1258–1262. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cote, L.P.; Greenberg, S.; Caprini, J.A.; Tafur, A.; Choi, C.; Muñoz, F.J.; Skride, A.; Valero, B.; Porras, J.A.; Ciammaichella, M.; et al. Comparisons Between Upper and Lower Extremity Deep Vein Thrombosis: A Review of the RIETE Registry. Clin. Appl. Thromb. Hemost. 2017, 23, 748–754. [Google Scholar] [CrossRef] [Green Version]
- Martinelli, I.; Battaglioli, T.; Bucciarelli, P.; Passamonti, S.M.; Mannucci, P.M. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 2004, 110, 566–570. [Google Scholar] [CrossRef] [Green Version]
- Mahmoud, O.; Vikatmaa, P.; Räsänen, J.; Peltola, E.; Sihvo, E.; Vikatmaa, L.; Lappalainen, K.; Venermo, M. Catheter-Directed Thrombolysis Versus Pharmacomechanical Thrombectomy for Upper Extremity Deep Venous Thrombosis: A Cost-Effectiveness Analysis. Ann. Vasc. Surg. 2018, 51. [Google Scholar] [CrossRef] [Green Version]
- Singhania, N.; Bansal, S.; Nimmatoori, D.P.; Ejaz, A.A.; McCullough, P.A.; Singhania, G. Current Overview on Hypercoagulability in COVID-19. Am. J. Cardiovasc. Drugs 2020, 20, 393–403. [Google Scholar] [CrossRef]
- Miesbach, W.; Makris, M. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clin. Appl. Thromb. Hemost. 2020, 26, 1076029620938149. [Google Scholar] [CrossRef]
- Yuan, Y.; Tu, J.; Lei, B.; Shu, H.; Zou, X.; Li, R.; Huang, C.; Qu, Y.; Shang, Y. Incidence and Risk Factors of Deep Vein Thrombosis in Hospitalized COVID-19 Patients. Clin. Appl. Thromb. Hemost. 2020, 26, 1076029620953217. [Google Scholar] [CrossRef]
- Zhang, L.; Feng, X.; Zhang, D.; Jiang, C.; Mei, H.; Wang, J.; Zhang, C.; Li, H.; Xia, X.; Kong, S.; et al. Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome. Circulation 2020, 142, 114–128. [Google Scholar] [CrossRef]
- Santoliquido, A.; Porfidia, A.; Nesci, A.; De Matteis, G.; Marrone, G.; Porceddu, E.; Cammà, G.; Giarretta, I.; Fantoni, M.; Landi, F.; et al. Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis. J. Thromb. Haemost. 2020, 18, 2358–2363. [Google Scholar] [CrossRef]
- Avruscio, G.; Camporese, G.; Campello, E.; Bernardi, E.; Persona, P.; Passarella, C.; Noventa, F.; Cola, M.; Navalesi, P.; Cattelan, A.; et al. COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward. Clin. Transl. Sci. 2020, 13, 1108–1114. [Google Scholar] [CrossRef]
- Asim, M.; Al-Thani, H.; El-Menyar, A. Recurrent Deep Vein Thrombosis after the First Venous Thromboembolism Event: A Single-Institution Experience. Med. Sci. Monit. 2017, 23, 2391–2399. [Google Scholar] [CrossRef] [Green Version]
- Labropoulos, N.; Jen, J.; Jen, H.; Gasparis, A.P.; Tassiopoulos, A.K. Recurrent deep vein thrombosis: Long-term incidence and natural history. Ann. Surg. 2010, 251, 749–753. [Google Scholar] [CrossRef]
- Demelo-Rodríguez, P.; Ordieres-Ortega, L.; Ji, Z.; Del Toro-Cervera, J.; de Miguel-Díez, J.; Álvarez-Sala-Walther, L.A.; Galeano-Valle, F. Long-term follow up of patients with venous thromboembolism and COVID-19: Analysis of risk factors for death and major bleeding [published online ahead of print, 2021 Feb 20]. Eur. J. Haematol. 2021. [Google Scholar] [CrossRef]
- Moores, L.K.; Tritschler, T.; Brosnahan, S.; Carrier, M.; Collen, J.F.; Doerschug, K.; Holley, A.B.; Jimenez, D.; Le Gal, G.; Rali, P.; et al. Prevention, diagnosis, and treatment of VTE in patients with Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report. Chest 2020, 158, 1143–1163. [Google Scholar] [CrossRef] [PubMed]
Reference Values (2017) | 1 January 2017 | Reference Values (2020) | 24 November 2020 | |
---|---|---|---|---|
PT 1 | 11.7–15 s | 14 | 9.2–11.7 s | 12.2 |
INR 2 | 0.81–1.20 | 1.10 | 0.88–1.13 | 1.17 |
aPTT 3 | 22.9–36.3 s | 35.4 | 21.7–30.5 s | 30.3 |
WBC | 4.5–11 × 103/μL | 3.9 | 4.5–11 × 103/μL | 3.7 |
RBC | 4.5–5.9 × 106/μL | 3.4 | 4.5–5.9 × 106/μL | 3.8 |
Hemoglobin | 11.6–16.3 g/dL | 10.5 | 11.6–16.3 g/dL | 11.5 |
Hematocrit | 40–52% | 32.5 | 40–52% | 36.6 |
Platelet | 150–400 × 103/μL | 99 | 150–400 × 103/μL | 89 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Parekh, Y.H.; Altomare, N.J.; McDonnell, E.P.; Blaser, M.J.; Parikh, P.D. Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19. Viruses 2021, 13, 878. https://doi.org/10.3390/v13050878
Parekh YH, Altomare NJ, McDonnell EP, Blaser MJ, Parikh PD. Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19. Viruses. 2021; 13(5):878. https://doi.org/10.3390/v13050878
Chicago/Turabian StyleParekh, Yesha H., Nicole J. Altomare, Erin P. McDonnell, Martin J. Blaser, and Payal D. Parikh. 2021. "Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19" Viruses 13, no. 5: 878. https://doi.org/10.3390/v13050878
APA StyleParekh, Y. H., Altomare, N. J., McDonnell, E. P., Blaser, M. J., & Parikh, P. D. (2021). Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19. Viruses, 13(5), 878. https://doi.org/10.3390/v13050878